bioRxiv Cancer Bio Profile
bioRxiv Cancer Bio

@biorxiv_cancer

Followers
2K
Following
0
Media
0
Statuses
6K

Joined July 2016
Don't wanna be here? Send us removal request.
@biorxiv_cancer
bioRxiv Cancer Bio
11 hours
DIFFERENTIAL ROLES OF RAD18 IN REPRESSING CARCINOGEN- AND ONCOGENE-DRIVEN MUTAGENESIS IN VIVO #biorxiv_cancer.
0
0
1
@biorxiv_cancer
bioRxiv Cancer Bio
13 hours
An organotypic in vitro model of human papillomavirus-associated precancerous lesions allowing automated cell quantification for . #biorxiv_cancer.
0
0
0
@biorxiv_cancer
bioRxiv Cancer Bio
13 hours
Spatial Proteomics of the Normal Breast Collagen Stroma: Links to BI-RADS Categories and Body Mass Index #biorxiv_cancer.
0
0
0
@biorxiv_cancer
bioRxiv Cancer Bio
14 hours
The IFN I response in tumor cells is shaped by PARP7-p300/CBP interactions through distinct loss- and gain-of-function mechanisms #biorxiv_cancer.
0
0
1
@biorxiv_cancer
bioRxiv Cancer Bio
14 hours
Bioelectric and Epigenetic Landscapes in Lateralized Breast Tumors Reveal Distinct Tumor Microenvironment Signatures. #biorxiv_cancer.
0
0
1
@biorxiv_cancer
bioRxiv Cancer Bio
17 hours
Multi-omic analysis of colorectal adenocarcinoma identifies a new subtype of myofibroblastic cancer-associated fibroblast expressing . #biorxiv_cancer.
0
0
0
@biorxiv_cancer
bioRxiv Cancer Bio
17 hours
Punctuated mutagenesis promotes multi-stepevolutionary adaptation in human cancers #biorxiv_cancer.
0
0
0
@biorxiv_cancer
bioRxiv Cancer Bio
1 day
Intrinsic higher potency of basal urothelial cells to intermediate and umbrella cells as the cell of origin for bladder cancer #biorxiv_cancer.
0
0
0
@biorxiv_cancer
bioRxiv Cancer Bio
2 days
Bedaquiline Amplifies Proteasome Inhibitor Efficacy and Overcomes Resistance in Multiple Myeloma #biorxiv_cancer.
0
0
0
@biorxiv_cancer
bioRxiv Cancer Bio
2 days
Cell Settling, Migration, and Stochastic Cancer Expression Suggest Potassium Flux Per H+- Sensitive KCN Members Associated with . #biorxiv_cancer.
0
0
0
@biorxiv_cancer
bioRxiv Cancer Bio
2 days
High Throughput Screening Identifies Small Molecules that Synergize with MRTX1133 Against Acquired Resistant KRAS G12D Mutated CRC #biorxiv_cancer.
0
0
0
@biorxiv_cancer
bioRxiv Cancer Bio
3 days
KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survival #biorxiv_cancer.
0
1
1
@biorxiv_cancer
bioRxiv Cancer Bio
3 days
KAT6A/B inhibition synergizes with retinoic acid and enhances the efficacy of GD2-targeted immunotherapy in neuroblastoma #biorxiv_cancer.
0
1
1
@biorxiv_cancer
bioRxiv Cancer Bio
3 days
Glioblastoma cells taste temozolomide via TAS2R43 #biorxiv_cancer.
0
1
0
@biorxiv_cancer
bioRxiv Cancer Bio
3 days
Cell enlargement causes mitotic errors and aneuploidy in cells that evade senescence after CDK4/6 inhibition #biorxiv_cancer.
0
3
3
@biorxiv_cancer
bioRxiv Cancer Bio
3 days
Single-Cell and Spatial Profiling of Tumor Microenvironment Heterogeneity in Human Osteosarcomas #biorxiv_cancer.
0
1
0
@biorxiv_cancer
bioRxiv Cancer Bio
3 days
cIAP1 inhibitor of apoptosis is a tumor suppressor in Ewing sarcoma #biorxiv_cancer.
0
1
1
@biorxiv_cancer
bioRxiv Cancer Bio
3 days
Circulating tumor cell heterogeneity and MMP9 expression in clinical correlation with breast cancer #biorxiv_cancer.
0
1
1
@biorxiv_cancer
bioRxiv Cancer Bio
3 days
Sweet taste receptor regulates proliferation and glucose uptake in glioblastoma cells #biorxiv_cancer.
0
1
0
@biorxiv_cancer
bioRxiv Cancer Bio
4 days
Intratumoral Treg ablation is sufficient to mediate tumor control systemically without autoimmunity #biorxiv_cancer.
0
1
1